Background: Borderline personality disorder (BPD) is a debilitating mental illness that affects approximately 6% of the general population and 10–20% of psychiatric patients. The Borderline Symptom List (BSL) is a self-report questionnaire designed to comprehensively assess BPD symptomatology. Sampling and Methods: The present study examined the convergence of the BSL with DSM-IV BPD assessed by semi-structured interview. To ensure variability in BPD symptoms, participants were recruited from a large college sample if they generated either high or low scores on a BPD symptom screening questionnaire. The final sample included 59 participants who completed the BSL, the BPD questions from the Structured Interview for DSM-IV Personality (SIDP-IV), and self-report measures of depression and anxiety. Results: Ten participants (17%) met the full BPD criteria and 29 (49%) met 2 or more criteria. Results indicate strong convergence between the BSL and BPD assessed by semi-structured interview, even when controlling for measures of depression and anxiety. The shortened version of the BSL, the BSL-23, also correlated robustly with BPD assessed by semi-structured interview. Conclusions: Findings support the validity of the BSL (and BSL-23) as a self-report measure of BPD symptomatology. Future research should replicate results in other samples, including those drawn from psychiatric populations.

Keywords:
Borderline symptom list, Borderline personality disorder, Assessment
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.